Match!
Marc W. Manseau
New York University
19Publications
9H-index
247Citations
Publications 19
Newest
Objective:Individuals with serious mental illness are overrepresented in correctional populations. However, little is known about the representation of persons with serious mental illness at earlie...
#1Adriana JosephH-Index: 2
#2Helen-Maria Lekas (NYU: New York University)H-Index: 14
Last.Crystal Fuller Lewis (NYU: New York University)H-Index: 6
view all 4 authors...
AbstractBackground: Epidemiologic reports available on synthetic cannabinoids (SCs) have focused on sociodemographics, indicating high prevalence of SC use predominantly among white, relatively affluent, males. However, there is emerging evidence suggesting high SC prevalence among socioeconomically disadvantaged, racial/ethnic minority males. Objectives: The purpose of this study is to investigate the risk correlates of SC use among psychosocial vulnerable communities. Method: The sample of 100...
#1Marc W. Manseau (NYU: New York University)H-Index: 9
#2Michael T. Compton (Columbia University)H-Index: 3
The Cannabis sativa plant contains many cannabinoids, including the principal psychoactive component, Δ 9 -terahydrocannabinol (THC), as well as cannabidiol (CBD). Cannabis is the most commonly used illicit drug globally. In recent years, its possession is being increasingly decriminalized and even legalized for both medical and recreational use in the United States and worldwide. Among the mental health concerns related to the drug, there is mounting evidence of an intricate link between cannab...
#1Marc W. Manseau (NYU: New York University)H-Index: 9
#2Amit Rajparia (NYU: New York University)H-Index: 4
Last.Crystal Fuller Lewis (NYU: New York University)H-Index: 6
view all 7 authors...
ABSTRACTBackground: Increasing reports of synthetic cannabinoid (SC)-related adverse events have largely comprised case reports and analyses of calls to poison control centers. Existing studies have also mostly involved white male populations. Objectives: The purpose of this study is to systematically describe clinical characteristics of SC use in a relatively large, diverse, urban sample presenting to a psychiatric emergency setting. Methods: SC users (n = 110) were identified by reviewing char...
#1Adriana Joseph (Nathan Kline Institute for Psychiatric Research)H-Index: 2
#2Marc W. Manseau (NYU: New York University)H-Index: 9
Last.Crystal Fuller Lewis (NYU: New York University)H-Index: 6
view all 5 authors...
ABSTRACTBackground: Growing evidence of adverse outcomes following synthetic cannabinoid use has engendered interest into populations at risk. The existing literature reports that synthetic cannabinoid use is predominant among young, white males. However, reports from local Departments of Health have found contrary evidence, showing that synthetic cannabinoid use is prevalent in populations other than those of young, white men. Objectives: This study sought to examine sociodemographic characteri...
#1Marc W. Manseau (NYU: New York University)H-Index: 9
#2Donald C. Goff (NYU: New York University)H-Index: 12
A convergence of evidence shows that use of Cannabis sativa is associated with increased risk of developing psychotic disorders, including schizophrenia, and earlier age at which psychotic symptoms first manifest. Cannabis exposure during adolescence is most strongly associated with the onset of psychosis amongst those who are particularly vulnerable, such as those who have been exposed to child abuse and those with family histories of schizophrenia. Schizophrenia that develops after cannabis us...
ObjectiveThe purpose of this study was to examine racial-ethnic differences in use of mental health treatment for a comprehensive range of specific disorders over time.MethodsData from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey were used to examine adult outpatient mental health visits to U.S. physicians from 1993 to 2008 (N=754,497). Annual visit prevalence for three racial-ethnic groups was estimated as the number of visits divided by t...
#1Joshua D. Lee (NYU: New York University)H-Index: 16
#2Ellie Grossman (NYU: New York University)H-Index: 11
Last.Marc N. Gourevitch (NYU: New York University)H-Index: 31
view all 8 authors...
Abstract The feasibility of long-term extended-release naltrexone (XR-NTX) alcohol treatment is unknown. Following an initial 12-week, single-arm, observational trial of XR-NTX plus medical management (MM) in primary care, we offered 48 additional weeks of XR-NTX treatment (12 additional monthly injections) in two public primary care clinics as a naturalistic extension study. Of 65 alcohol dependent adults initiating XR-NTX treatment, 40 (62%) completed the initial 12-week XR-NTX observational t...
12